Welcome To Seminar ON Drug Regulatory Affairs: Preparad by:K.SLRAO (Mpharm.1yr)
Welcome To Seminar ON Drug Regulatory Affairs: Preparad by:K.SLRAO (Mpharm.1yr)
Welcome To Seminar ON Drug Regulatory Affairs: Preparad by:K.SLRAO (Mpharm.1yr)
Preparad by:K.SLRAO(mpharm.1yr)
DEFINATION:
the industries. Regulations are put in order to develop the most efficient and safe pharmaceutical products. It takes more than 8 to 15 years to develop a new drug product & costs more than $ 800 million. Regulatory affairs provides insight/guidance into this development through agency wisdom collected in guidance, previous experience, market precedence, etc. and hence helps to reduce number of development failures
TGA- Australia
MCC- (Medicines Control Council) South Africa Product Development Clinical Research & Trials Licensing
Manufacturing
Quality Assurance & control Marketing
Licensing Registration
Development
Manufacturing Quality Guidance Pricing Marketing
Pharmacovigilance
GMP ,GLP ,GCP, Patent, Copyright ,Trademark
regulatory Authorities, Eg. Mfg. License, GMP, CoPP, ISO etc. Common Technical Document (CTD/eCTD) ASEAN Common Technical Document (ACTD) Drug Master File Clinical Trial Reports Bioavailability & Bioequivalence reports Quality Audit files and reports &
review and submit annual drug reviews, adverse drug experience, recall coordination activities and different regulatory guidelines answer and negotiate with the drug regulatory authorities on various issues on drug registration. apply for the various certifications and arrange for the audit and also work on their renewal. .& many more.
The above discussion proves that the DRA department is providing its full support to all the department of a pharmaceutical organization and also to the Drug Regulatory authorities on all aspects of Drug development process.
This in turn helps to avoid any delay or
problems that can arise in future relating to the Product, hence save a lot of time, efforts and expenditure
THANK YOU